vs

Side-by-side financial comparison of Abbott Laboratories (ABT) and Warby Parker Inc. (WRBY). Click either name above to swap in a different company.

Abbott Laboratories is the larger business by last-quarter revenue ($11.5B vs $212.0M, roughly 54.1× Warby Parker Inc.). Abbott Laboratories runs the higher net margin — 15.5% vs -2.8%, a 18.3% gap on every dollar of revenue. On growth, Warby Parker Inc. posted the faster year-over-year revenue change (11.2% vs 4.4%). Abbott Laboratories produced more free cash flow last quarter ($2.6B vs $8.1M). Over the past eight quarters, Abbott Laboratories's revenue compounded faster (7.2% CAGR vs 2.9%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

Warby Parker Inc. is an American eyewear brand and retailer of prescription glasses, contact lenses, and sunglasses, based in New York City. It also offers eye exams. Originally founded in 2010 as an online-only retailer, the company now generates about two-thirds of its revenue from its 276 physical retail stores, 271 of which are in the U.S. and 5 of which are in Canada. The company intends to operate 900 stores. The company has 2.28 million customers; average order value is $263.

ABT vs WRBY — Head-to-Head

Bigger by revenue
ABT
ABT
54.1× larger
ABT
$11.5B
$212.0M
WRBY
Growing faster (revenue YoY)
WRBY
WRBY
+6.8% gap
WRBY
11.2%
4.4%
ABT
Higher net margin
ABT
ABT
18.3% more per $
ABT
15.5%
-2.8%
WRBY
More free cash flow
ABT
ABT
$2.6B more FCF
ABT
$2.6B
$8.1M
WRBY
Faster 2-yr revenue CAGR
ABT
ABT
Annualised
ABT
7.2%
2.9%
WRBY

Income Statement — Q4 2025 vs Q4 2025

Metric
ABT
ABT
WRBY
WRBY
Revenue
$11.5B
$212.0M
Net Profit
$1.8B
$-6.0M
Gross Margin
57.0%
52.4%
Operating Margin
19.6%
-3.2%
Net Margin
15.5%
-2.8%
Revenue YoY
4.4%
11.2%
Net Profit YoY
-80.8%
13.4%
EPS (diluted)
$1.01
$-0.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ABT
ABT
WRBY
WRBY
Q4 25
$11.5B
$212.0M
Q3 25
$11.4B
$221.7M
Q2 25
$11.1B
$214.5M
Q1 25
$10.4B
$223.8M
Q4 24
$11.0B
$190.6M
Q3 24
$10.6B
$192.4M
Q2 24
$10.4B
$188.2M
Q1 24
$10.0B
$200.0M
Net Profit
ABT
ABT
WRBY
WRBY
Q4 25
$1.8B
$-6.0M
Q3 25
$1.6B
$5.9M
Q2 25
$1.8B
$-1.8M
Q1 25
$1.3B
$3.5M
Q4 24
$9.2B
$-6.9M
Q3 24
$1.6B
$-4.1M
Q2 24
$1.3B
$-6.8M
Q1 24
$1.2B
$-2.7M
Gross Margin
ABT
ABT
WRBY
WRBY
Q4 25
57.0%
52.4%
Q3 25
55.4%
54.1%
Q2 25
56.4%
53.0%
Q1 25
56.9%
56.3%
Q4 24
55.0%
54.1%
Q3 24
55.8%
54.5%
Q2 24
55.6%
56.0%
Q1 24
55.2%
56.7%
Operating Margin
ABT
ABT
WRBY
WRBY
Q4 25
19.6%
-3.2%
Q3 25
18.1%
1.6%
Q2 25
18.4%
-2.1%
Q1 25
16.3%
1.1%
Q4 24
17.4%
-4.9%
Q3 24
17.5%
-3.4%
Q2 24
16.1%
-4.8%
Q1 24
13.9%
-2.6%
Net Margin
ABT
ABT
WRBY
WRBY
Q4 25
15.5%
-2.8%
Q3 25
14.5%
2.6%
Q2 25
16.0%
-0.8%
Q1 25
12.8%
1.6%
Q4 24
84.1%
-3.6%
Q3 24
15.5%
-2.1%
Q2 24
12.5%
-3.6%
Q1 24
12.3%
-1.3%
EPS (diluted)
ABT
ABT
WRBY
WRBY
Q4 25
$1.01
$-0.06
Q3 25
$0.94
$0.05
Q2 25
$1.01
$-0.01
Q1 25
$0.76
$0.03
Q4 24
$5.26
$-0.06
Q3 24
$0.94
$-0.03
Q2 24
$0.74
$-0.06
Q1 24
$0.70
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ABT
ABT
WRBY
WRBY
Cash + ST InvestmentsLiquidity on hand
$8.9B
$286.4M
Total DebtLower is stronger
$12.9B
Stockholders' EquityBook value
$52.1B
$367.7M
Total Assets
$86.7B
$720.9M
Debt / EquityLower = less leverage
0.25×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ABT
ABT
WRBY
WRBY
Q4 25
$8.9B
$286.4M
Q3 25
$7.7B
$280.4M
Q2 25
$7.3B
$286.4M
Q1 25
$6.8B
$265.1M
Q4 24
$8.0B
$254.2M
Q3 24
$7.8B
$251.0M
Q2 24
$7.2B
$238.0M
Q1 24
$6.7B
$220.4M
Total Debt
ABT
ABT
WRBY
WRBY
Q4 25
$12.9B
Q3 25
Q2 25
Q1 25
Q4 24
$14.1B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ABT
ABT
WRBY
WRBY
Q4 25
$52.1B
$367.7M
Q3 25
$51.0B
$369.6M
Q2 25
$50.6B
$361.5M
Q1 25
$48.8B
$354.1M
Q4 24
$47.7B
$340.1M
Q3 24
$39.8B
$336.8M
Q2 24
$39.3B
$329.4M
Q1 24
$38.8B
$316.2M
Total Assets
ABT
ABT
WRBY
WRBY
Q4 25
$86.7B
$720.9M
Q3 25
$84.2B
$706.9M
Q2 25
$84.0B
$701.9M
Q1 25
$81.4B
$682.8M
Q4 24
$81.4B
$676.5M
Q3 24
$74.4B
$638.0M
Q2 24
$73.0B
$618.2M
Q1 24
$72.5B
$592.9M
Debt / Equity
ABT
ABT
WRBY
WRBY
Q4 25
0.25×
Q3 25
Q2 25
Q1 25
Q4 24
0.30×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ABT
ABT
WRBY
WRBY
Operating Cash FlowLast quarter
$3.3B
$23.3M
Free Cash FlowOCF − Capex
$2.6B
$8.1M
FCF MarginFCF / Revenue
22.9%
3.8%
Capex IntensityCapex / Revenue
6.0%
7.1%
Cash ConversionOCF / Net Profit
1.87×
TTM Free Cash FlowTrailing 4 quarters
$7.4B
$43.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ABT
ABT
WRBY
WRBY
Q4 25
$3.3B
$23.3M
Q3 25
$2.8B
$18.0M
Q2 25
$2.0B
$40.2M
Q1 25
$1.4B
$29.4M
Q4 24
$2.9B
$19.9M
Q3 24
$2.7B
$27.3M
Q2 24
$2.0B
$31.6M
Q1 24
$1.0B
$19.9M
Free Cash Flow
ABT
ABT
WRBY
WRBY
Q4 25
$2.6B
$8.1M
Q3 25
$2.3B
$-1.5M
Q2 25
$1.5B
$23.9M
Q1 25
$933.0M
$13.2M
Q4 24
$2.1B
$2.2M
Q3 24
$2.1B
$13.1M
Q2 24
$1.4B
$14.0M
Q1 24
$627.0M
$5.5M
FCF Margin
ABT
ABT
WRBY
WRBY
Q4 25
22.9%
3.8%
Q3 25
20.2%
-0.7%
Q2 25
13.9%
11.1%
Q1 25
9.0%
5.9%
Q4 24
19.6%
1.1%
Q3 24
20.2%
6.8%
Q2 24
13.8%
7.4%
Q1 24
6.3%
2.7%
Capex Intensity
ABT
ABT
WRBY
WRBY
Q4 25
6.0%
7.1%
Q3 25
4.4%
8.8%
Q2 25
4.5%
7.6%
Q1 25
4.7%
7.2%
Q4 24
6.6%
9.3%
Q3 24
5.2%
7.4%
Q2 24
5.1%
9.4%
Q1 24
4.0%
7.2%
Cash Conversion
ABT
ABT
WRBY
WRBY
Q4 25
1.87×
Q3 25
1.70×
3.06×
Q2 25
1.15×
Q1 25
1.07×
8.46×
Q4 24
0.31×
Q3 24
1.64×
Q2 24
1.51×
Q1 24
0.84×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ABT
ABT

Segment breakdown not available.

WRBY
WRBY

Retail$155.2M73%
E Commerce$56.8M27%

Related Comparisons